{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:15:30Z","timestamp":1774642530309,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.sapharm.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T09:06:41Z","timestamp":1584436001000},"page":"419-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of a medication management program targeting hypertension and diabetes patients: Impact on medication adherence"],"prefix":"10.1016","volume":"17","author":[{"given":"Sunmee","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euna","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Soon","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Yeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2020.03.002_bib1","author":"Kosis"},{"issue":"44","key":"10.1016\/j.sapharm.2020.03.002_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005286","article-title":"Prevalence of chronic disease and its controlled status according to income level","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.sapharm.2020.03.002_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","article-title":"Aging: a common driver of chronic diseases and a target for novel interventions","volume":"159","author":"Kennedy","year":"2014","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.sapharm.2020.03.002_bib4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/ijms.10001","article-title":"Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention","volume":"11","author":"Wu","year":"2014","journal-title":"Int J Med Sci"},{"issue":"6865","key":"10.1016\/j.sapharm.2020.03.002_bib5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.sapharm.2020.03.002_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2105\/AJPH.90.9.1409","article-title":"A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women","volume":"90","author":"Liu","year":"2000","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.sapharm.2020.03.002_bib8","unstructured":"UN. World Population Prospects: The 2012 Revision. Accessed June 2013."},{"key":"10.1016\/j.sapharm.2020.03.002_bib9","series-title":"World Health Statistics 2012","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.sapharm.2020.03.002_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2337\/diacare.25.6.1015","article-title":"The association between diabetes metabolic control and drug adherence in an indigent population","volume":"25","author":"Schectman","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib11","first-page":"239","article-title":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations","volume":"12","author":"Bramley","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.sapharm.2020.03.002_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11906-015-0606-5","article-title":"Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis","volume":"17","author":"Conn","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.sapharm.2020.03.002_bib14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diacare.27.5.1218","article-title":"A systematic review of adherence with medications for diabetes","volume":"27","author":"Cramer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1185\/03007995.2015.1053048","article-title":"Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes","volume":"31","author":"Iglay","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"10.1016\/j.sapharm.2020.03.002_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186458","article-title":"Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence","volume":"12","author":"N\u00e1fr\u00e1di","year":"2017","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.sapharm.2020.03.002_bib17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00228-014-1761-3","article-title":"Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature","volume":"70","author":"Kelly","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2020.03.002_bib18","series-title":"Adherence to Long-Term Therapies-Evidence for Action","author":"Who","year":"2003"},{"issue":"14","key":"10.1016\/j.sapharm.2020.03.002_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006577","article-title":"Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea","volume":"96","author":"Kim","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"23","key":"10.1016\/j.sapharm.2020.03.002_bib20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2020.03.002_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40885-018-0098-0","article-title":"The Korean society hypertension, hypertension epidemiology research working group","volume":"24","author":"Kim","year":"2018","journal-title":"Clin Hyper"},{"key":"10.1016\/j.sapharm.2020.03.002_bib22","author":"Korea Diabetes Association"},{"issue":"1","key":"10.1016\/j.sapharm.2020.03.002_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5414\/CP202409","article-title":"Patient response to insurer-led intervention for medication adherence - a pilot study based on claims data in Korea","volume":"54","author":"Sohn","year":"2016","journal-title":"Int J Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.sapharm.2020.03.002_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.sapharm.2015.06.001","article-title":"Medication adherence interventions that target subjects with adherence problems: systematic review and meta-analysis","volume":"12","author":"Conn","year":"2016","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2020.03.002_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","article-title":"Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review","volume":"157","author":"Viswanathan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.sapharm.2020.03.002_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/pop.2008.0046","article-title":"Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting","volume":"12","author":"Stacy","year":"2009","journal-title":"Popul Health Manag"},{"issue":"6","key":"10.1016\/j.sapharm.2020.03.002_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinternmed.2011.1977","article-title":"Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial","volume":"172","author":"Solomon","year":"2012","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.sapharm.2020.03.002_bib28","first-page":"SP79","article-title":"Use of health information technology to improve medication adherence","volume":"17","author":"Vollmer","year":"2011","journal-title":"Am J Manag Care"},{"issue":"5","key":"10.1016\/j.sapharm.2020.03.002_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamainternmed.2016.9627","article-title":"Effect of reminder devices on medication adherence: the REMIND randomized clinical trial","volume":"177","author":"Choudhry","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.sapharm.2020.03.002_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ypmed.2017.07.019","article-title":"The effect of interactive reminders on medication adherence: a randomized trial","volume":"103","author":"Dai","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/j.sapharm.2020.03.002_bib31","first-page":"38","article-title":"Medication adherence study looks at types of interventions","volume":"23","author":"Jones","year":"2014","journal-title":"Manag Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ajh.2009.210","article-title":"Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan","volume":"23","author":"Wu","year":"2010","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.sapharm.2020.03.002_bib33","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.sapharm.2020.03.002_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1345\/aph.1L496","article-title":"Comparison of methods to assess medication adherence and classify nonadherence","volume":"43","author":"Hansen","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2020.03.002_bib35","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.sapharm.2014.02.001","article-title":"Outcomes of good medication persistence for chronic diseases","author":"Han","year":"2014","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2020.03.002_bib36","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1742-1241.2010.02445.x","article-title":"On behalf of the ASCOT trial investigators. The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial","volume":"64","author":"Lindgren","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sapharm.2020.03.002_bib37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MLR.0b013e31820292d1","article-title":"Relationship between oral anti hyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea","volume":"49","author":"Hong","year":"2011","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-6-48","article-title":"Adherence to cardio-protective medications and mortality amoba1ng patients with diabetes and ischemic heart disease","volume":"6","author":"Ho","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.sapharm.2020.03.002_bib39","series-title":"Methods for the Control of Measured Confounders in Outcomes Research","author":"Jang","year":"2013"},{"issue":"5","key":"10.1016\/j.sapharm.2020.03.002_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.sapharm.2020.03.002_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"ABC Project Team. A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2020.03.002_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.15585\/mmwr.mm6645a2","article-title":"CDC grand rounds. Improving medication adherence for chronic disease management \u2014 innovations and opportunities","volume":"66","author":"Neiman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2020.03.002_bib44","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diacare.27.5.1218","article-title":"A systematic review of adherence with medications for diabetes","volume":"27","author":"Cramer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2020.03.002_bib45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","article-title":"The significance of adherence and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review","volume":"62","author":"Cramer","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"8","key":"10.1016\/j.sapharm.2020.03.002_bib46","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/heartjnl-2012-303004","article-title":"EASY-IMPACT investigators telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation","volume":"99","author":"Rinfret","year":"2013","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.sapharm.2020.03.002_bib47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1331\/JAPhA.2012.11001","article-title":"MAP study: RCT of a medication adherence program for patients with type 2 diabetes","volume":"52","author":"Odegard","year":"2012","journal-title":"J Am Pharmaceut Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2020.03.002_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jamacardio.2016.0251","article-title":"Implementation of a regional telephone cardiopulmonary resuscitation program and outcomes after out-of-hospital cardiac arrest","volume":"1","author":"Bobrow","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.sapharm.2020.03.002_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2710.2010.01218.x","article-title":"Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial","volume":"36","author":"Mehuys","year":"2011","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.sapharm.2020.03.002_bib50","first-page":"CD000011","article-title":"Interventions for enhancing medication adherence","volume":"2","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2020.03.002_bib51","first-page":"CD000011","article-title":"Interventions for enhancing medication adherence","volume":"11","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.sapharm.2020.03.002_bib52","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.sapharm.2018.09.021","article-title":"Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis","volume":"15","author":"Presley","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2020.03.002_bib53","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sapharm.2016.08.005","article-title":"Pharmacist-led medication review in community settings: an overview of systematic reviews","volume":"13","author":"Jokanovic","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2020.03.002_bib54","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","article-title":"Hypertension outcome and surveillance team of the Canadian hypertension education programs. Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan","year":"2009","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.sapharm.2020.03.002_bib55","first-page":"1052","article-title":"Validity of health administrative database definitions for hypertension: a systematic review","volume":"33","author":"Pace","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.sapharm.2020.03.002_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jclinepi.2018.03.004","article-title":"Association measures of claims-based algorithms for common chronic conditions were assessed using regularly collected data in Japan","volume":"99","author":"Hara","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.sapharm.2020.03.002_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1062860606288243","article-title":"Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression","volume":"21","author":"Solberg","year":"2006","journal-title":"Am J Med Qual"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741119306539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741119306539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:22:14Z","timestamp":1761556934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741119306539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1551741119306539"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2020.03.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of a medication management program targeting hypertension and diabetes patients: Impact on medication adherence","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}